메뉴 건너뛰기




Volumn 11, Issue 7, 2015, Pages

The Broad Neutralizing Antibody Responses after HIV-1 Superinfection Are Not Dominated by Antibodies Directed to Epitopes Common in Single Infection

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CORE PROTEIN; EPITOPE; GLYCOPROTEIN GP 41; NEUTRALIZING ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

EID: 84938808649     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004973     Document Type: Article
Times cited : (28)

References (66)
  • 1
    • 84926634007 scopus 로고    scopus 로고
    • Ending the global HIV/AIDS pandemic: the critical role of an HIV vaccine
    • Fauci AS, Folkers GK, Marston HD, (2014) Ending the global HIV/AIDS pandemic: the critical role of an HIV vaccine. CLIN INFECT DIS 59 Suppl 2: S80–S84. doi: 10.1093/cid/ciu420 25151483
    • (2014) CLIN INFECT DIS , vol.59 , pp. S80-S84
    • Fauci, A.S.1    Folkers, G.K.2    Marston, H.D.3
  • 2
    • 84879290459 scopus 로고    scopus 로고
    • A global approach to HIV-1 vaccine development
    • Stephenson KE, Barouch DH, (2013) A global approach to HIV-1 vaccine development. Immunol Rev 254: 295–304. doi: 10.1111/imr.12073 23772627
    • (2013) Immunol Rev , vol.254 , pp. 295-304
    • Stephenson, K.E.1    Barouch, D.H.2
  • 3
    • 84904124681 scopus 로고    scopus 로고
    • A critical question for HIV vaccine development: Which antibodies to induce?
    • Zolla-Pazner S, (2014) A critical question for HIV vaccine development: Which antibodies to induce? Science 345: 167–168. doi: 10.1126/science.1256526 25013066
    • (2014) Science , vol.345 , pp. 167-168
    • Zolla-Pazner, S.1
  • 4
    • 69249208675 scopus 로고    scopus 로고
    • Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors
    • Gray ES, Taylor N, Wycuff D, Moore PL, Tomaras GD, et al. (2009) Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors. Journal of Virology 83: 8925–8937. doi: 10.1128/JVI.00758-09 19553335
    • (2009) Journal of Virology , vol.83 , pp. 8925-8937
    • Gray, E.S.1    Taylor, N.2    Wycuff, D.3    Moore, P.L.4    Tomaras, G.D.5
  • 5
    • 84863769888 scopus 로고    scopus 로고
    • The development of CD4 binding site antibodies during HIV-1 infection
    • Lynch RM, Tran L, Louder MK, Schmidt SD, Cohen M, et al. (2012) The development of CD4 binding site antibodies during HIV-1 infection. Journal of Virology 86: 7588–7595. doi: 10.1128/JVI.00734-12 22573869
    • (2012) Journal of Virology , vol.86 , pp. 7588-7595
    • Lynch, R.M.1    Tran, L.2    Louder, M.K.3    Schmidt, S.D.4    Cohen, M.5
  • 6
    • 79955389756 scopus 로고    scopus 로고
    • The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection
    • Gray ES, Madiga MC, Hermanus T, Moore PL, Wibmer CK, et al. (2011) The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection. Journal of Virology 85: 4828–4840. doi: 10.1128/JVI.00198-11 21389135
    • (2011) Journal of Virology , vol.85 , pp. 4828-4840
    • Gray, E.S.1    Madiga, M.C.2    Hermanus, T.3    Moore, P.L.4    Wibmer, C.K.5
  • 7
    • 70350320582 scopus 로고    scopus 로고
    • Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region
    • Gray ES, Madiga MC, Moore PL, Mlisana K, Karim SSA, et al. (2009) Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region. Journal of Virology 83: 11265–11274. doi: 10.1128/JVI.01359-09 19692477
    • (2009) Journal of Virology , vol.83 , pp. 11265-11274
    • Gray, E.S.1    Madiga, M.C.2    Moore, P.L.3    Mlisana, K.4    Karim, S.S.A.5
  • 8
    • 77958115264 scopus 로고    scopus 로고
    • A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals
    • Walker LM, Simek MD, Priddy F, Gach JS, Wagner D, et al. (2010) A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals. PLoS Pathog 6.
    • (2010) PLoS Pathog , vol.6
    • Walker, L.M.1    Simek, M.D.2    Priddy, F.3    Gach, J.S.4    Wagner, D.5
  • 9
    • 80055104586 scopus 로고    scopus 로고
    • Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals
    • Tomaras GD, Binley JM, Gray ES, Crooks ET, Osawa K, et al. (2011) Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals. Journal of Virology 85: 11502–11519. doi: 10.1128/JVI.05363-11 21849452
    • (2011) Journal of Virology , vol.85 , pp. 11502-11519
    • Tomaras, G.D.1    Binley, J.M.2    Gray, E.S.3    Crooks, E.T.4    Osawa, K.5
  • 10
    • 56449131391 scopus 로고    scopus 로고
    • Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C
    • Binley JM, Lybarger EA, Crooks ET, Seaman MS, Gray E, et al. (2008) Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. Journal of Virology 82: 11651–11668. doi: 10.1128/JVI.01762-08 18815292
    • (2008) Journal of Virology , vol.82 , pp. 11651-11668
    • Binley, J.M.1    Lybarger, E.A.2    Crooks, E.T.3    Seaman, M.S.4    Gray, E.5
  • 11
    • 77952516203 scopus 로고    scopus 로고
    • Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjects
    • Sather DN, Stamatatos L, (2010) Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjects. Vaccine 28: B8–B12. doi: 10.1016/j.vaccine.2009.07.085 20510750
    • (2010) Vaccine , vol.28 , pp. B8-B12
    • Sather, D.N.1    Stamatatos, L.2
  • 12
    • 79551518897 scopus 로고    scopus 로고
    • Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
    • Mikell I, Sather DN, Kalams SA, Altfeld M, Alter G, et al. (2011) Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1. PLoS Pathog 7: e1001251. doi: 10.1371/journal.ppat.1001251 21249232
    • (2011) PLoS Pathog , vol.7 , pp. e1001251
    • Mikell, I.1    Sather, D.N.2    Kalams, S.A.3    Altfeld, M.4    Alter, G.5
  • 13
    • 84866493348 scopus 로고    scopus 로고
    • Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
    • Huang J, Ofek G, Laub L, Louder MK, Doria-Rose NA, et al. (2012) Broad and potent neutralization of HIV-1 by a gp41-specific human antibody. Nature 491: 406–412. doi: 10.1038/nature11544 23151583
    • (2012) Nature , vol.491 , pp. 406-412
    • Huang, J.1    Ofek, G.2    Laub, L.3    Louder, M.K.4    Doria-Rose, N.A.5
  • 14
    • 0034759882 scopus 로고    scopus 로고
    • Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41
    • Zwick MB, Labrijn AF, Wang M, Spenlehauer C, Saphire EO, et al. (2001) Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. Journal of Virology 75: 10892–10905. 11602729
    • (2001) Journal of Virology , vol.75 , pp. 10892-10905
    • Zwick, M.B.1    Labrijn, A.F.2    Wang, M.3    Spenlehauer, C.4    Saphire, E.O.5
  • 15
    • 0028593629 scopus 로고
    • A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1
    • Purtscher M, Trkola A, Gruber G, Buchacher A, Predl R, et al. (1994) A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 10: 1651–1658. 7888224
    • (1994) AIDS Res Hum Retroviruses , vol.10 , pp. 1651-1658
    • Purtscher, M.1    Trkola, A.2    Gruber, G.3    Buchacher, A.4    Predl, R.5
  • 16
    • 77954920017 scopus 로고    scopus 로고
    • Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
    • Wu X, Yang Z-Y, Li Y, Hogerkorp C-M, Schief WR, et al. (2010) Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1. Science.
    • (2010)
    • Wu, X.1    Yang, Z.-Y.2    Li, Y.3    Hogerkorp, C.-M.4    Schief, W.R.5
  • 17
    • 80052925616 scopus 로고    scopus 로고
    • Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
    • Scheid JF, Mouquet H, Ueberheide B, Diskin R, Klein F, et al. (2011) Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding. Science 333: 1633–1637. doi: 10.1126/science.1207227 21764753
    • (2011) Science , vol.333 , pp. 1633-1637
    • Scheid, J.F.1    Mouquet, H.2    Ueberheide, B.3    Diskin, R.4    Klein, F.5
  • 18
    • 82755184131 scopus 로고    scopus 로고
    • Increasing the potency and breadth of an HIV antibody by using structure-based rational design
    • Diskin R, Scheid JF, Marcovecchio PM, West AP, Klein F, et al. (2011) Increasing the potency and breadth of an HIV antibody by using structure-based rational design. Science 334: 1289–1293. doi: 10.1126/science.1213782 22033520
    • (2011) Science , vol.334 , pp. 1289-1293
    • Diskin, R.1    Scheid, J.F.2    Marcovecchio, P.M.3    West, A.P.4    Klein, F.5
  • 19
    • 77649318846 scopus 로고    scopus 로고
    • Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals
    • Corti D, Langedijk JPM, Hinz A, Seaman MS, Vanzetta F, et al. (2010) Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals. PLoS ONE 5: e8805. doi: 10.1371/journal.pone.0008805 20098712
    • (2010) PLoS ONE , vol.5 , pp. e8805
    • Corti, D.1    Langedijk, J.P.M.2    Hinz, A.3    Seaman, M.S.4    Vanzetta, F.5
  • 20
    • 70349887757 scopus 로고    scopus 로고
    • Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target
    • Walker LM, Phogat SK, Chan-Hui P-Y, Wagner D, Phung P, et al. (2009) Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326: 285–289. doi: 10.1126/science.1178746 19729618
    • (2009) Science , vol.326 , pp. 285-289
    • Walker, L.M.1    Phogat, S.K.2    Chan-Hui, P.-Y.3    Wagner, D.4    Phung, P.5
  • 22
    • 84900467984 scopus 로고    scopus 로고
    • Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers
    • Blattner C, Lee JH, Sliepen K, Derking R, Falkowska E, et al. (2014) Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers. Immunity 40: 669–680. doi: 10.1016/j.immuni.2014.04.008 24768348
    • (2014) Immunity , vol.40 , pp. 669-680
    • Blattner, C.1    Lee, J.H.2    Sliepen, K.3    Derking, R.4    Falkowska, E.5
  • 23
    • 84900517557 scopus 로고    scopus 로고
    • Broadly Neutralizing HIV Antibodies Definea Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers
    • Falkowska E, Le KM, Ramos A, Doores KJ, Lee JH, et al. (2014) Broadly Neutralizing HIV Antibodies Definea Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers. Immunity 40: 657–668. doi: 10.1016/j.immuni.2014.04.009 24768347
    • (2014) Immunity , vol.40 , pp. 657-668
    • Falkowska, E.1    Le, K.M.2    Ramos, A.3    Doores, K.J.4    Lee, J.H.5
  • 24
    • 84899909771 scopus 로고    scopus 로고
    • Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike
    • Scharf L, Scheid JF, Lee JH, West AP, JrChen C, et al. (2014) Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike. CellReports 7: 785–795.
    • (2014) CellReports , vol.7 , pp. 785-795
    • Scharf, L.1    Scheid, J.F.2    Lee, J.H.3    West, A.P.4    Chen, C.5
  • 25
    • 84921607768 scopus 로고    scopus 로고
    • Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface
    • Huang J, Kang BH, Pancera M, Lee JH, Tong T, et al. (2014) Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface. Nature 515: 138–142. http://www.nature.com/doifinder/10.1038/nature13601. doi: 10.1038/nature13601 25186731
    • (2014) Nature , vol.515 , pp. 138-142
    • Huang, J.1    Kang, B.H.2    Pancera, M.3    Lee, J.H.4    Tong, T.5
  • 26
    • 77956048307 scopus 로고    scopus 로고
    • Infection by discordant strains of HIV-1 markedly enhances the neutralizing antibody response against heterologous virus
    • Powell RLR, Kinge T, Nyambi PN, (2010) Infection by discordant strains of HIV-1 markedly enhances the neutralizing antibody response against heterologous virus. Journal of Virology 84: 9415–9426. doi: 10.1128/JVI.02732-09 20631143
    • (2010) Journal of Virology , vol.84 , pp. 9415-9426
    • Powell, R.L.R.1    Kinge, T.2    Nyambi, P.N.3
  • 27
    • 84861217014 scopus 로고    scopus 로고
    • HIV-1 Superinfection in Women Broadens and Strengthens the Neutralizing Antibody Response
    • Cortez V, Odem-Davis K, McClelland RS, Jaoko W, Overbaugh J, (2012) HIV-1 Superinfection in Women Broadens and Strengthens the Neutralizing Antibody Response. PLoS Pathog 8: e1002611. doi: 10.1371/journal.ppat.1002611 22479183
    • (2012) PLoS Pathog , vol.8 , pp. e1002611
    • Cortez, V.1    Odem-Davis, K.2    McClelland, R.S.3    Jaoko, W.4    Overbaugh, J.5
  • 28
    • 23244453195 scopus 로고    scopus 로고
    • Evidence for frequent reinfection with human immunodeficiency virus type 1 of a different subtype
    • Chohan B, Lavreys L, Rainwater SMJ, Overbaugh J, (2005) Evidence for frequent reinfection with human immunodeficiency virus type 1 of a different subtype. Journal of Virology 79: 10701–10708. 16051862
    • (2005) Journal of Virology , vol.79 , pp. 10701-10708
    • Chohan, B.1    Lavreys, L.2    Rainwater, S.M.J.3    Overbaugh, J.4
  • 30
    • 51849094531 scopus 로고    scopus 로고
    • Examination of a second region of the HIV type 1 genome reveals additional cases of superinfection
    • Piantadosi A, Ngayo MO, Chohan B, Overbaugh J, (2008) Examination of a second region of the HIV type 1 genome reveals additional cases of superinfection. AIDS Res Hum Retroviruses 24: 1221. doi: 10.1089/aid.2008.0100 18729772
    • (2008) AIDS Res Hum Retroviruses , vol.24 , pp. 1221
    • Piantadosi, A.1    Ngayo, M.O.2    Chohan, B.3    Overbaugh, J.4
  • 31
    • 84883414441 scopus 로고    scopus 로고
    • HIV-1 Superinfection Occurs Less Frequently Than Initial Infection in a Cohort of High-Risk Kenyan Women
    • Ronen K, McCoy CO, Matsen FA, Boyd DF, Emery S, et al. (2013) HIV-1 Superinfection Occurs Less Frequently Than Initial Infection in a Cohort of High-Risk Kenyan Women. PLoS Pathog 9: e1003593. doi: 10.1371/journal.ppat.1003593 24009513
    • (2013) PLoS Pathog , vol.9 , pp. e1003593
    • Ronen, K.1    McCoy, C.O.2    Matsen, F.A.3    Boyd, D.F.4    Emery, S.5
  • 32
    • 84909606569 scopus 로고    scopus 로고
    • HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencing
    • Carter CC, Wagner GA, Hightower GK, Caballero G, Phung P, et al. (2015) HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencing. Virology 474: 34–40. doi: 10.1016/j.virol.2014.10.019 25463602
    • (2015) Virology , vol.474 , pp. 34-40
    • Carter, C.C.1    Wagner, G.A.2    Hightower, G.K.3    Caballero, G.4    Phung, P.5
  • 33
    • 33744904454 scopus 로고    scopus 로고
    • Neutralizing Antibody Responses against Autologous and Heterologous Viruses in Acute versus Chronic Human Immunodeficiency Virus (HIV) Infection: Evidence for a Constraint on the Ability of HIV To Completely Evade Neutralizing Antibody Responses
    • Deeks SG, Schweighardt B, Wrin T, Galovich J, Hoh R, et al. (2006) Neutralizing Antibody Responses against Autologous and Heterologous Viruses in Acute versus Chronic Human Immunodeficiency Virus (HIV) Infection: Evidence for a Constraint on the Ability of HIV To Completely Evade Neutralizing Antibody Responses. Journal of Virology 80: 6155–6164. 16731954
    • (2006) Journal of Virology , vol.80 , pp. 6155-6164
    • Deeks, S.G.1    Schweighardt, B.2    Wrin, T.3    Galovich, J.4    Hoh, R.5
  • 34
    • 70349298392 scopus 로고    scopus 로고
    • Breadth of Neutralizing Antibody Response to Human Immunodeficiency Virus Type 1 Is Affected by Factors Early in Infection but Does Not Influence Disease Progression
    • Piantadosi A, Panteleeff D, Blish CA, Baeten JM, Jaoko W, et al. (2009) Breadth of Neutralizing Antibody Response to Human Immunodeficiency Virus Type 1 Is Affected by Factors Early in Infection but Does Not Influence Disease Progression. Journal of Virology 83: 10269–10274. doi: 10.1128/JVI.01149-09 19640996
    • (2009) Journal of Virology , vol.83 , pp. 10269-10274
    • Piantadosi, A.1    Panteleeff, D.2    Blish, C.A.3    Baeten, J.M.4    Jaoko, W.5
  • 35
    • 58149487645 scopus 로고    scopus 로고
    • Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection
    • Sather DN, Armann J, Ching LK, Mavrantoni A, Sellhorn G, et al. (2009) Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection. Journal of Virology 83: 757–769. doi: 10.1128/JVI.02036-08 18987148
    • (2009) Journal of Virology , vol.83 , pp. 757-769
    • Sather, D.N.1    Armann, J.2    Ching, L.K.3    Mavrantoni, A.4    Sellhorn, G.5
  • 36
    • 77957573505 scopus 로고    scopus 로고
    • The humoral response to HIV-1: new insights, renewed focus
    • Alter G, Moody MA, (2010) The humoral response to HIV-1: new insights, renewed focus. J INFECT DIS 202 Suppl 2: S315–S322. doi: 10.1086/655654 20846039
    • (2010) J INFECT DIS , vol.202 , pp. S315-S322
    • Alter, G.1    Moody, M.A.2
  • 37
    • 84880161438 scopus 로고    scopus 로고
    • Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
    • Kong L, Lee JH, Doores KJ, Murin CD, Julien J-P, et al. (2013) Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Nat Struct Mol Biol 20: 796–803. doi: 10.1038/nsmb.2594 23708606
    • (2013) Nat Struct Mol Biol , vol.20 , pp. 796-803
    • Kong, L.1    Lee, J.H.2    Doores, K.J.3    Murin, C.D.4    Julien, J.-P.5
  • 38
    • 84901236516 scopus 로고    scopus 로고
    • Promiscuous Glycan Site Recognition by Antibodies to the High-Mannose Patch of gp120 Broadens Neutralization of HIV
    • Sok D, Doores KJ, Briney B, Le KM, Saye-Francisco KL, et al. (2014) Promiscuous Glycan Site Recognition by Antibodies to the High-Mannose Patch of gp120 Broadens Neutralization of HIV. Sci Transl Med 6: 236ra63–236ra63. doi: 10.1126/scitranslmed.3008104 24828077
    • (2014) Sci Transl Med , vol.6 , pp. 236ra63-236ra63
    • Sok, D.1    Doores, K.J.2    Briney, B.3    Le, K.M.4    Saye-Francisco, K.L.5
  • 39
    • 84899991983 scopus 로고    scopus 로고
    • Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
    • Doria-Rose NA, Schramm CA, Gorman J, Moore PL, Bhiman JN, et al. (2014) Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature.
    • (2014)
    • Doria-Rose, N.A.1    Schramm, C.A.2    Gorman, J.3    Moore, P.L.4    Bhiman, J.N.5
  • 40
    • 79952579682 scopus 로고    scopus 로고
    • Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop
    • Moore PL, Gray ES, Sheward D, Madiga M, Ranchobe N, et al. (2011) Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop. Journal of Virology 85: 3128–3141. doi: 10.1128/JVI.02658-10 21270156
    • (2011) Journal of Virology , vol.85 , pp. 3128-3141
    • Moore, P.L.1    Gray, E.S.2    Sheward, D.3    Madiga, M.4    Ranchobe, N.5
  • 41
    • 84926453015 scopus 로고    scopus 로고
    • Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
    • Derking R, Ozorowski G, Sliepen K, Yasmeen A, Cupo A, et al. (2015) Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer. PLoS Pathog 11: e1004767. doi: 10.1371/journal.ppat.1004767 25807248
    • (2015) PLoS Pathog , vol.11 , pp. e1004767
    • Derking, R.1    Ozorowski, G.2    Sliepen, K.3    Yasmeen, A.4    Cupo, A.5
  • 42
    • 84880431984 scopus 로고    scopus 로고
    • The N276 Glycosylation Site Is Required for HIV-1 Neutralization by the CD4 Binding Site Specific HJ16 Monoclonal Antibody
    • Balla-Jhagjhoorsingh SS, Corti D, Heyndrickx L, Willems E, Vereecken K, et al. (2013) The N276 Glycosylation Site Is Required for HIV-1 Neutralization by the CD4 Binding Site Specific HJ16 Monoclonal Antibody. PLoS ONE 8: e68863. doi: 10.1371/journal.pone.0068863 23874792
    • (2013) PLoS ONE , vol.8 , pp. e68863
    • Balla-Jhagjhoorsingh, S.S.1    Corti, D.2    Heyndrickx, L.3    Willems, E.4    Vereecken, K.5
  • 43
    • 84920771783 scopus 로고    scopus 로고
    • Two Classes of Broadly Neutralizing Antibodies within a Single Lineage Directed to the High-Mannose Patch of HIV Envelope
    • Doores KJ, Kong L, Krumm SA, Le KM, Sok D, et al. (2015) Two Classes of Broadly Neutralizing Antibodies within a Single Lineage Directed to the High-Mannose Patch of HIV Envelope. Journal of Virology 89: 1105–1118. doi: 10.1128/JVI.02905-14 25378488
    • (2015) Journal of Virology , vol.89 , pp. 1105-1118
    • Doores, K.J.1    Kong, L.2    Krumm, S.A.3    Le, K.M.4    Sok, D.5
  • 44
    • 84876333290 scopus 로고    scopus 로고
    • Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies
    • Moore PL, Sheward D, Nonyane M, Ranchobe N, Hermanus T, et al. (2013) Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies. Journal of Virology 87: 4882–4894. doi: 10.1128/JVI.03424-12 23408621
    • (2013) Journal of Virology , vol.87 , pp. 4882-4894
    • Moore, P.L.1    Sheward, D.2    Nonyane, M.3    Ranchobe, N.4    Hermanus, T.5
  • 45
    • 84887270287 scopus 로고    scopus 로고
    • Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes
    • Wibmer CK, Bhiman JN, Gray ES, Tumba N, Karim SSA, et al. (2013) Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes. PLoS Pathog 9: e1003738. doi: 10.1371/journal.ppat.1003738 24204277
    • (2013) PLoS Pathog , vol.9 , pp. e1003738
    • Wibmer, C.K.1    Bhiman, J.N.2    Gray, E.S.3    Tumba, N.4    Karim, S.S.A.5
  • 46
    • 84860723906 scopus 로고    scopus 로고
    • Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design
    • Bonsignori M, Montefiori DC, Wu X, Chen X, Hwang K-K, et al. (2012) Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design. Journal of Virology 86: 4688–4692. doi: 10.1128/JVI.07163-11 22301150
    • (2012) Journal of Virology , vol.86 , pp. 4688-4692
    • Bonsignori, M.1    Montefiori, D.C.2    Wu, X.3    Chen, X.4    Hwang, K.-K.5
  • 47
    • 84877618448 scopus 로고    scopus 로고
    • Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization
    • Georgiev IS, Doria-Rose NA, Zhou T, Kwon YD, Staupe RP, et al. (2013) Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization. Science 340: 751–756. doi: 10.1126/science.1233989 23661761
    • (2013) Science , vol.340 , pp. 751-756
    • Georgiev, I.S.1    Doria-Rose, N.A.2    Zhou, T.3    Kwon, Y.D.4    Staupe, R.P.5
  • 48
    • 84893570591 scopus 로고    scopus 로고
    • Ending AIDS—is an HIV vaccine necessary?
    • Fauci AS, Marston HD, (2014) Ending AIDS—is an HIV vaccine necessary? N Engl J Med 370: 495–498. doi: 10.1056/NEJMp1313771 24499210
    • (2014) N Engl J Med , vol.370 , pp. 495-498
    • Fauci, A.S.1    Marston, H.D.2
  • 49
    • 84866495323 scopus 로고    scopus 로고
    • Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies
    • Kwong PD, Mascola JR, (2012) Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies. Immunity 37: 412–425. doi: 10.1016/j.immuni.2012.08.012 22999947
    • (2012) Immunity , vol.37 , pp. 412-425
    • Kwong, P.D.1    Mascola, J.R.2
  • 50
    • 84869155712 scopus 로고    scopus 로고
    • Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape
    • Moore PL, Moore PL, Gray ES, Gray ES, Wibmer CK, et al. (2012) Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape. Nat Med 18: 1688. doi: 10.1038/nm.2985 23086475
    • (2012) Nat Med , vol.18 , pp. 1688
    • Moore, P.L.1    Moore, P.L.2    Gray, E.S.3    Gray, E.S.4    Wibmer, C.K.5
  • 52
    • 84870701546 scopus 로고    scopus 로고
    • Broadly neutralizing antibodies against HIV-1: templates for a vaccine
    • Van Gils MJ, Sanders RW, (2013) Broadly neutralizing antibodies against HIV-1: templates for a vaccine. Virology 435: 46–56. doi: 10.1016/j.virol.2012.10.004 23217615
    • (2013) Virology , vol.435 , pp. 46-56
    • Van Gils, M.J.1    Sanders, R.W.2
  • 53
    • 0034469170 scopus 로고    scopus 로고
    • The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors
    • Malenbaum SE, Yang D, Cavacini L, Posner M, Robinson J, et al. (2000) The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors. Journal of Virology 74: 11008–11016. 11069996
    • (2000) Journal of Virology , vol.74 , pp. 11008-11016
    • Malenbaum, S.E.1    Yang, D.2    Cavacini, L.3    Posner, M.4    Robinson, J.5
  • 54
    • 0041920924 scopus 로고    scopus 로고
    • Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition
    • Koch M, Pancera M, Kwong PD, Kolchinsky P, Grundner C, et al. (2003) Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition. Virology 313: 387–400. 12954207
    • (2003) Virology , vol.313 , pp. 387-400
    • Koch, M.1    Pancera, M.2    Kwong, P.D.3    Kolchinsky, P.4    Grundner, C.5
  • 55
    • 84890859441 scopus 로고    scopus 로고
    • Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer
    • Lyumkis D, Julien J-P, De Val N, Cupo A, Potter CS, et al. (2013) Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science 342: 1484–1490. doi: 10.1126/science.1245627 24179160
    • (2013) Science , vol.342 , pp. 1484-1490
    • Lyumkis, D.1    Julien, J.-P.2    De Val, N.3    Cupo, A.4    Potter, C.S.5
  • 56
    • 84880184277 scopus 로고    scopus 로고
    • Development of prophylactic vaccines against HIV-1
    • Schiffner T, Sattentau QJ, Dorrell L, (2013) Development of prophylactic vaccines against HIV-1. Retrovirology 10: 72. doi: 10.1186/1742-4690-10-72 23866844
    • (2013) Retrovirology , vol.10 , pp. 72
    • Schiffner, T.1    Sattentau, Q.J.2    Dorrell, L.3
  • 57
    • 84883796903 scopus 로고    scopus 로고
    • Antibodies in HIV-1 vaccine development and therapy
    • Klein F, Mouquet H, Dosenovic P, Scheid JF, Scharf L, et al. (2013) Antibodies in HIV-1 vaccine development and therapy. Science 341: 1199–1204. doi: 10.1126/science.1241144 24031012
    • (2013) Science , vol.341 , pp. 1199-1204
    • Klein, F.1    Mouquet, H.2    Dosenovic, P.3    Scheid, J.F.4    Scharf, L.5
  • 58
    • 84894173514 scopus 로고    scopus 로고
    • Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy
    • West AP, Scharf L, Scheid JF, Klein F, Bjorkman PJ, et al. (2014) Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy. Cell 156: 633–648. doi: 10.1016/j.cell.2014.01.052 24529371
    • (2014) Cell , vol.156 , pp. 633-648
    • West, A.P.1    Scharf, L.2    Scheid, J.F.3    Klein, F.4    Bjorkman, P.J.5
  • 59
    • 84869062790 scopus 로고    scopus 로고
    • A combination of broadly neutralizing HIV-1 monoclonal antibodies targeting distinct epitopes effectively neutralizes variants found in early infection
    • Goo L, Jalalian-Lechak Z, Richardson BA, Overbaugh J, (2012) A combination of broadly neutralizing HIV-1 monoclonal antibodies targeting distinct epitopes effectively neutralizes variants found in early infection. Journal of Virology 86: 10857–10861. doi: 10.1128/JVI.01414-12 22837204
    • (2012) Journal of Virology , vol.86 , pp. 10857-10861
    • Goo, L.1    Jalalian-Lechak, Z.2    Richardson, B.A.3    Overbaugh, J.4
  • 60
    • 84879111348 scopus 로고    scopus 로고
    • HIV-1 maternal and infant variants show similar sensitivity to broadly neutralizing antibodies, but sensitivity varies by subtype
    • Mabuka J, Goo L, Omenda MM, Nduati R, Overbaugh J, (2013) HIV-1 maternal and infant variants show similar sensitivity to broadly neutralizing antibodies, but sensitivity varies by subtype. AIDS 27: 1535–1544. doi: 10.1097/QAD.0b013e32835faba5 23856624
    • (2013) AIDS , vol.27 , pp. 1535-1544
    • Mabuka, J.1    Goo, L.2    Omenda, M.M.3    Nduati, R.4    Overbaugh, J.5
  • 61
    • 84863269120 scopus 로고    scopus 로고
    • HIV-1 neutralization coverage is improved by combining monoclonal antibodies that target independent epitopes
    • Doria-Rose NA, Louder MK, Yang Z, O'Dell S, Nason M, et al. (2012) HIV-1 neutralization coverage is improved by combining monoclonal antibodies that target independent epitopes. Journal of Virology 86: 3393–3397. doi: 10.1128/JVI.06745-11 22258252
    • (2012) Journal of Virology , vol.86 , pp. 3393-3397
    • Doria-Rose, N.A.1    Louder, M.K.2    Yang, Z.3    O'Dell, S.4    Nason, M.5
  • 62
    • 84887626950 scopus 로고    scopus 로고
    • Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
    • Barouch DH, Whitney JB, Moldt B, Klein F, Oliveira TY, et al. (2013) Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys. Nature 503: 224–228. doi: 10.1038/nature12744 24172905
    • (2013) Nature , vol.503 , pp. 224-228
    • Barouch, D.H.1    Whitney, J.B.2    Moldt, B.3    Klein, F.4    Oliveira, T.Y.5
  • 63
    • 84887627657 scopus 로고    scopus 로고
    • Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
    • Shingai M, Nishimura Y, Klein F, Mouquet H, Donau OK, et al. (2013) Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia. Nature 503: 277–280. doi: 10.1038/nature12746 24172896
    • (2013) Nature , vol.503 , pp. 277-280
    • Shingai, M.1    Nishimura, Y.2    Klein, F.3    Mouquet, H.4    Donau, O.K.5
  • 64
    • 0027998192 scopus 로고
    • Preparation for AIDS vaccine evaluation in Mombasa, Kenya: establishment of seronegative cohorts of commercial sex workers and trucking company employees
    • Martin HL, Jackson DJ, Mandaliya K, Bwayo J, Rakwar JP, et al. (1994) Preparation for AIDS vaccine evaluation in Mombasa, Kenya: establishment of seronegative cohorts of commercial sex workers and trucking company employees. AIDS Res Hum Retroviruses 10 Suppl 2: S235–S237. 7865309
    • (1994) AIDS Res Hum Retroviruses , vol.10 , pp. S235-S237
    • Martin, H.L.1    Jackson, D.J.2    Mandaliya, K.3    Bwayo, J.4    Rakwar, J.P.5
  • 65
    • 30344485709 scopus 로고    scopus 로고
    • Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant
    • Wu X, Parast AB, Richardson BA, Nduati R, John-Stewart G, et al. (2006) Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant. Journal of Virology 80: 835–844. 16378985
    • (2006) Journal of Virology , vol.80 , pp. 835-844
    • Wu, X.1    Parast, A.B.2    Richardson, B.A.3    Nduati, R.4    John-Stewart, G.5
  • 66
    • 20844448731 scopus 로고    scopus 로고
    • Antigenic conservation and immunogenicity of the HIV coreceptor binding site
    • Decker JM, Bibollet-Ruche F, Wei X, Wang S, Levy DN, et al. (2005) Antigenic conservation and immunogenicity of the HIV coreceptor binding site. J Exp Med 201: 1407–1419. 15867093
    • (2005) J Exp Med , vol.201 , pp. 1407-1419
    • Decker, J.M.1    Bibollet-Ruche, F.2    Wei, X.3    Wang, S.4    Levy, D.N.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.